Recipients who developed post-LT AKI were noted to have been generally older, had higher MELD scores, less frequently presented with HCC, had pre-LT HTN, relatively lower preoperative serum albumin level, and had more blood loss than those in the no post-LT AKI group (p < 0.05) in Table 1. The gene discussed is ALB; the disease is hepatocellular carcinoma.